Upper Tract Urothelial Carcinoma

Sequential Endoluminal Chemotherapy for Non-Invasive High-Grade UTUC
Vignesh T. Packiam, MD, of Rutgers Cancer Institute, and Katie S. Murray, DO, MS, of NYU Langone Urology and Bellevue Hospital, weigh multiple recent studies that explore the efficacy of gemcitabine/docetaxel as a frontline therapy for upper tract urothelial carcinoma, highlighting its potential as an alternative to BCG amid supply shortages and its promising outcomes in preserving kidney function. ...
Advertisement

Latest News

Advertisement

Roundtable Discussions

Urothelial Cancer Knowledge Hubs

Curated clinical content based on urothelial cancer types, therapies, and technologies

Urothelial Carcinoma
Urothelial Carcinoma
Advertisement
Section Editor

Advertisement
Get the latest UTUC research straight to your inbox.